UFPT
UFP Technologies, Inc. · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | 0 | 5.60M | $1.48B | +5 | −5 |
| Q1 2026 | 87 | -2 | 5.05M | $977.88M | +5 | −7 |
| Q4 2025 | 89 | -3 | 5.34M | $1.19B | — | −3 |
| Q3 2025 | 18 | 0 | 2.83M | $564.24M | — | — |
| Q2 2025 | 15 | +2 | 2.67M | $652.20M | +2 | — |
| Q1 2025 | 10 | -1 | 1.10M | $222.08M | +1 | −2 |
| Q4 2024 | 11 | 0 | 1.06M | $258.43M | +1 | −1 |
| Q3 2024 | 10 | 0 | 609.62K | $193.08M | +1 | −1 |
| Q2 2024 | 10 | — | 642.12K | $169.45M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 293.61K | — | $77.48M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 169.66K | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 169.66K | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 106.83K | — | $28.19M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 106.83K | — | $28.19M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 26.71K | — | $7.05M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 20.19K | — | $5.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 20.19K | — | $5.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 20.19K | — | $5.33M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 9.14K | — | $2.41M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 9.14K | — | $2.41M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 7.29K | — | $1.92M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 7.29K | — | $1.92M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 5.97K | — | $1.58M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.87K | — | $493,965 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 835 | — | $220,331 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 271 holders, 8.76M shares, $1.58B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 298 sh · $95,095
Director · 1.93K sh · $625,141
Director · 1.00K sh · $324,260
Officer, Director · 6.87K sh · $2.17M
Officer, Director · 5.77K sh · $1.82M
Officer, Director · 374 sh · $118,659
Officer, Director · 542 sh · $170,763
Officer, Director · 4.47K sh · $1.42M
Officer, Director · 7.88K sh · $2.51M
Officer, Director · 2.81K sh · $897,740
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology